Short Interest in Silo Pharma, Inc. (NASDAQ:SILO) Drops By 22.8%

Silo Pharma, Inc. (NASDAQ:SILO) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 155,700 shares, a decline of 22.8% from the January 31st total of 201,600 shares. Based on an average daily volume of 3,060,000 shares, the short-interest ratio is currently 0.1 days. Currently, 3.6% of the shares of the company are short sold.

Silo Pharma Price Performance

Shares of NASDAQ SILO traded up $0.01 during midday trading on Thursday, hitting $1.28. 3,638 shares of the stock traded hands, compared to its average volume of 4,322,954. Silo Pharma has a one year low of $0.77 and a one year high of $4.50. The firm has a 50-day moving average of $1.51 and a two-hundred day moving average of $1.23.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.